Enveda Biosciences

Engineering New Drugs from Nature

Hybrid

Some members of the team work remotely, while others are co-located in one or more offices.

💼Healthcare

👥201-500

📍Boulder, CO

Enveda Biosciences

About Enveda Biosciences

Enveda Biosciences is a biotechnology company engineering new drugs from nature.

What Enveda Biosciences is building

At Enveda, we are systematically translating molecules found in medicinal plants into new drugs for challenging diseases. Our platform harnesses nature's complexity with the help of cutting-edge advancements in knowledge graphs, machine learning, and metabolomics.

Funding rounds

Total Funding

$186.4M

Last funding round type

Venture - Series Unknown

Company type

For Profit

Enveda Biosciences news and updates

Envedabio received financing of $68M in equity and debt financing on Dec 21st 22'.

Biotech startup Enveda Biosciences has closed on $68 million in debt and equity.

Dec 20, 2022 | pitchbook.com

Envedabio launched mass spectrometry and automation laboratory on Apr 1st 22'.

Since Then : In April, Enveda announced a new mass spectrometry and automation laboratory in Boulder.

Oct 26, 2022 | biospace.com

Envedabio expands offices in India

Enveda can expand its space in Hyderabad to accommodate nearly triple its current workforce.

Jan 1, 2022 | businesswire.com

Envedabio hired Robert J. Buckley as Chief People Officer on Apr 21st 22'.

Enveda Biosciences, a leading biotechnology company harnessing the power of nature’s chemistry to develop next-generation small molecule drugs, today announced the appointment of Robert J. Buckley as its Chief People Officer.

Jan 1, 2022 | businesswire.com

Envedabio invests into assets : facilities

“They’re a big reason why Envedabio is investing in its new facilities.

Jan 1, 2022 | businesswire.com

Envedabio is developing core set of enabling libraries and tools

Enveda Biosciences is hiring a Senior Software Engineer to develop a core set of enabling libraries and tools using cutting-edge technologies and deliver scalable, robust solutions.

Jan 1, 2022 | nextpittsburgh.com

Envedabio hired Vanitha Sekar as Chief Business Officer on Jul 14th 22'.

Enveda Biosciences, a pioneer in transforming small molecule drug discovery by using machine learning and metabolomics to harness the potential of natural products, today announced the appointment of Vanitha Sekar, Ph.D., R.Ph., to the newly created position of Chief Business Officer.

Jan 1, 2022 | yahoo.com

Envedabio receives financing of $4.9M in seed round

Enveda Biosciences has raised a seed round of $4.9 million to build what it touts to be the “world’s largest database of anthropological, chemical and biological data from medicinal plants.”

Jan 1, 2020 | crunchbase.com